More radionuclide therapy is better for prostate cancer patients

(Society of Nuclear Medicine) For prostate cancer patients with bone metastases, repeated administrations of radionuclide therapy with 188Re-HEDP are shown to improve overall survival rates and reduce pain, according to new research published in the November issue of the Journal of Nuclear Medicine.